Review paper
Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis
Abstract
Type I autoimmune pancreatitis (AIP) and IgG4-related sclerosing cholangitis (IgG4-SC) belong to the IgG4-related disease (IgG4-RD) spectrum. Both entities respond to glucocorticoids, but iatrogenic toxicity associated with prolonged steroid therapy and relapse represent relevant clinical concerns in the long-term. Rituximab is increasingly used as an effective alternative strategy to induce remission but data regarding the safety and efficacy...
Paper Details
Title
Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis
Published Date
Oct 1, 2021
Journal
Volume
21
Issue
7
Pages
1395 - 1401
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History